Pathogenesis of Oral Type I Feline Infectious Peritonitis Virus (FIPV) Infection: Antibody-dependent Enhancement Infection of Cats with Type I FIPV Via the Oral Route

Overview

Journal J Vet Med Sci

Specialty Veterinary Medicine

Date 2019 Apr 26

PMID 31019150

Citations 30

Authors

Tomomi Takano

Shinji Yamada

Tomoyoshi Doki

Tsutomu Hohdatsu

Affiliations

Soon will be listed here.

Abstract

Feline infectious peritonitis virus (FIPV) causes a severe, immune-mediated disease called FIP in domestic and wild cats. It is unclear whether FIP transmits from cat to cat through the oral route of FIPV infection, and the reason for this includes that FIP is caused by oral inoculation with some FIPV strains (e.g., type II FIPV WSU 79-1146), but is not caused by other FIPV (e.g., type I FIPV KU-2 strain: FIPV-I KU-2). In this study, when cats passively immunized with anti-FIPV-I KU-2 antibodies were orally inoculated with FIPV-I KU-2, FIP was caused at a 50% probability, i.e., FIPV not causing FIP through oral infection caused FIP by inducing antibody-dependent enhancement. Many strains of type I FIPV do not cause FIP by inoculation through the oral route in cats. Based on the findings of this study, type I FIPV which orally infected cats may cause FIP depending on the condition.

Citing Articles

Antibody-dependent enhancement of coronaviruses.

Tao T, Tian L, Ke J, Zhang C, Li M, Xu X Int J Biol Sci. 2025; 21(4):1686-1704.

PMID: 39990674 PMC: 11844293. DOI: 10.7150/ijbs.96112.

A review of feline infectious peritonitis virus infection.

Solikhah T, Agustin Q, Damaratri R, Siwi D, Rafiuttaqi G, Hartadi V Vet World. 2025; 17(11):2417-2432.

PMID: 39829669 PMC: 11736369. DOI: 10.14202/vetworld.2024.2417-2432.

Genetic and Phylogenetic Analysis of Feline Coronavirus in Guangxi Province of China from 2021 to 2024.

Shi K, He M, Shi Y, Long F, Shi Y, Yin Y Vet Sci. 2024; 11(10).

PMID: 39453047 PMC: 11512343. DOI: 10.3390/vetsci11100455.

Feline Infectious Peritonitis mRNA Vaccine Elicits Both Humoral and Cellular Immune Responses in Mice.

Brostoff T, Savage H, Jackson K, Dutra J, Fontaine J, Hartigan-OConnor D Vaccines (Basel). 2024; 12(7).

PMID: 39066343 PMC: 11281389. DOI: 10.3390/vaccines12070705.

Antibody-Dependent Enhancement with a Focus on SARS-CoV-2 and Anti-Glycan Antibodies.

Ziganshina M, Shilova N, Khalturina E, Dolgushina N, V Borisevich S, Yarotskaya E Viruses. 2023; 15(7).

PMID: 37515270 PMC: 10384250. DOI: 10.3390/v15071584.

References

Takada A, Kawaoka Y . Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev Med Virol. 2003; 13(6):387-98. DOI: 10.1002/rmv.405. View

Kaneshima T, Hohdatsu T, Satoh K, Takano T, Motokawa K, Koyama H . The prevalence of a group 2 coronavirus in dogs in Japan. J Vet Med Sci. 2006; 68(1):21-5. DOI: 10.1292/jvms.68.21. View

Hohdatsu T, Nakamura M, Ishizuka Y, Yamada H, Koyama H . A study on the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection in feline macrophages by monoclonal antibodies. Arch Virol. 1991; 120(3-4):207-17. PMC: 7087175. DOI: 10.1007/BF01310476. View

Takano T, Hohdatsu T, Toda A, Tanabe M, Koyama H . TNF-alpha, produced by feline infectious peritonitis virus (FIPV)-infected macrophages, upregulates expression of type II FIPV receptor feline aminopeptidase N in feline macrophages. Virology. 2007; 364(1):64-72. PMC: 7103289. DOI: 10.1016/j.virol.2007.02.006. View

Tekes G, Hofmann-Lehmann R, Stallkamp I, Thiel V, Thiel H . Genome organization and reverse genetic analysis of a type I feline coronavirus. J Virol. 2007; 82(4):1851-9. PMC: 2258703. DOI: 10.1128/JVI.02339-07. View

Takano T, Kawakami C, Yamada S, Satoh R, Hohdatsu T . Antibody-dependent enhancement occurs upon re-infection with the identical serotype virus in feline infectious peritonitis virus infection. J Vet Med Sci. 2009; 70(12):1315-21. DOI: 10.1292/jvms.70.1315. View

Addie D, Belak S, Boucraut-Baralon C, Egberink H, Frymus T, Gruffydd-Jones T . Feline infectious peritonitis. ABCD guidelines on prevention and management. J Feline Med Surg. 2009; 11(7):594-604. PMC: 7129471. DOI: 10.1016/j.jfms.2009.05.008. View

Chang H, de Groot R, Egberink H, Rottier P . Feline infectious peritonitis: insights into feline coronavirus pathobiogenesis and epidemiology based on genetic analysis of the viral 3c gene. J Gen Virol. 2009; 91(Pt 2):415-20. DOI: 10.1099/vir.0.016485-0. View

Kipar A, Meli M, Baptiste K, Bowker L, Lutz H . Sites of feline coronavirus persistence in healthy cats. J Gen Virol. 2010; 91(Pt 7):1698-707. DOI: 10.1099/vir.0.020214-0. View

10.

Takano T, Tomiyama Y, Katoh Y, Nakamura M, Satoh R, Hohdatsu T . Mutation of neutralizing/antibody-dependent enhancing epitope on spike protein and 7b gene of feline infectious peritonitis virus: influences of viral replication in monocytes/macrophages and virulence in cats. Virus Res. 2011; 156(1-2):72-80. PMC: 7114493. DOI: 10.1016/j.virusres.2010.12.020. View

11.

Satoh R, Furukawa T, Kotake M, Takano T, Motokawa K, Gemma T . Screening and identification of T helper 1 and linear immunodominant antibody-binding epitopes in the spike 2 domain and the nucleocapsid protein of feline infectious peritonitis virus. Vaccine. 2011; 29(9):1791-800. PMC: 7115570. DOI: 10.1016/j.vaccine.2010.12.106. View

12.

Chang H, Egberink H, Halpin R, Spiro D, Rottier P . Spike protein fusion peptide and feline coronavirus virulence. Emerg Infect Dis. 2012; 18(7):1089-95. PMC: 3376813. DOI: 10.3201/eid1807.120143. View

13.

Licitra B, Millet J, Regan A, Hamilton B, Rinaldi V, Duhamel G . Mutation in spike protein cleavage site and pathogenesis of feline coronavirus. Emerg Infect Dis. 2013; 19(7):1066-73. PMC: 3713968. DOI: 10.3201/eid1907.121094. View

14.

Pedersen N . An update on feline infectious peritonitis: virology and immunopathogenesis. Vet J. 2014; 201(2):123-32. PMC: 7110662. DOI: 10.1016/j.tvjl.2014.04.017. View

15.

Takano T, Hohdatsu T . Serological diagnosis of feline coronavirus infection by immunochromatographic test. Methods Mol Biol. 2015; 1282:33-9. PMC: 7122596. DOI: 10.1007/978-1-4939-2438-7_3. View

16.

Tekes G, Thiel H . Feline Coronaviruses: Pathogenesis of Feline Infectious Peritonitis. Adv Virus Res. 2016; 96:193-218. PMC: 7112361. DOI: 10.1016/bs.aivir.2016.08.002. View

17.

Pedersen N . Virologic and immunologic aspects of feline infectious peritonitis virus infection. Adv Exp Med Biol. 1987; 218:529-50. DOI: 10.1007/978-1-4684-1280-2_69. View

18.

Takano T, Endoh M, Fukatsu H, Sakurada H, Doki T, Hohdatsu T . The cholesterol transport inhibitor U18666A inhibits type I feline coronavirus infection. Antiviral Res. 2017; 145:96-102. PMC: 7113792. DOI: 10.1016/j.antiviral.2017.07.022. View

19.

Jaimes J, Whittaker G . Feline coronavirus: Insights into viral pathogenesis based on the spike protein structure and function. Virology. 2018; 517:108-121. PMC: 7112122. DOI: 10.1016/j.virol.2017.12.027. View

20.

Ehmann R, Kristen-Burmann C, Bank-Wolf B, Konig M, Herden C, Hain T . Reverse Genetics for Type I Feline Coronavirus Field Isolate To Study the Molecular Pathogenesis of Feline Infectious Peritonitis. mBio. 2018; 9(4). PMC: 6069117. DOI: 10.1128/mBio.01422-18. View